Hyperuricemia is a Risk Factor for One-Year Overall Survival in Elderly Female Patients with Acute Coronary Syndrome. (22nd February 2020)

• Record Type: Journal Article
• Authors: Tai, Shi; Li, Xuping; Zhu, Zhaowei; Tang, Liang; Yang, Hui; Fu, Liyao; Hu, Xinqun; Fang, Zhenfei; Zhou, Shenghua
• Other Names: Puthanveetil Prasanth Academic Editor.
• Is Part Of: Cardiovascular therapeutics. Volume 2020(2020)
• Publication Date: 2020-02-22
• Subjects: Cardiovascular pharmacology -- Periodicals; Cardiovascular agents -- Periodicals; Cardiovascular system -- Diseases -- Chemotherapy -- Periodicals; Cardiovascular Agents -- Periodicals; Cardiovascular Diseases -- drug therapy -- Periodicals; Agents cardiovasculaires -- Périodiques; Appareil cardiovasculaire -- Maladies -- Chimiothérapie -- Périodiques; 616.1005
• DOI: 10.1155/2020/2615147
• Languages: English
• ISSNs: 1755-5914

Abstract

Abstract : Background . Hyperuricemia is a risk factor for cardiovascular diseases, but the impact of hyperuricemia and sex-related disparities is not fully clear in elderly patients with acute coronary syndrome (ACS). Objective . To investigate the association between hyperuricemia and 1-year all-cause mortality in elderly patients with ACS. Methods . This retrospective cohort study included 711 consecutive ACS patients aged ≥75 years, hospitalized in our center between January 2013 and December 2017. Serum uric acid (sUA), in-hospital events, and 1-year follow-up were analyzed. Multivariable logistic regression models were used to explore the risk factors for in-hospital events and 1-year all-cause mortality. Results . sUA levels were higher in males than in females (381.4 ± 110.1 vs. 349.3 ± 119.1 μ mol/l, P < 0.001 ). Prevalence of hypertension (80.5% vs. 72.6%, P = 0.020 ), atrial fibrillation (16.2% vs. 9.5%, P = 0.008 ), and severe heart failure (61.0% vs. 44.2%, P < 0.001 ) were higher in patients with hyperuricemia than in patients with normal sUA. During the 1-year follow-up, 135 patients died (19.0%); all-cause mortality was higher in patients with hyperuricemia than in patients with normal sUA (23.1% vs. 16.7%, P = 0.039 ). Hyperuricemia is related to in-hospital ventricular tachycardia and 1-year all-cause mortality (OR = 1.799, 95% CI 1.050–3.081, P = 0.033 ; OR = 1.512, 95% CI 1.028–2.225, P = 0.036, respectively). Multivariable regression analysis models showed that hyperuricemia was an independent risk factor of 1-year all-cause mortality in women (OR = 2.539, 95% CI 1.001–6.453, P = 0.050 ), but not in men (OR = 0.931, 95% CI 0.466–1.858, P = 0.839 ) after adjustment for confounding variables. Conclusions . Hyperuricemia is an independent risk factor for 1-year all-cause mortality in elderly female patients with ACS.